Xiaoying Zhou, Mona Correa, Dino Athanasiadis, Veronica T. Benites, Bryce Doherty, Lucy Edy, Christy Piamonte, Gener Eliares, Marvin Cornejo, Ting Gong, Leon Parker, Manuel Oliveira, Walter Rakitsky, James Casey Lippmeier, Jessica M. Walter, Frédéric Destaillats
Palmitoleic acid (POA; 16:1 n-7 or cis-9 16:1) is a bioactive monounsaturated fatty acid (FA) with emerging metabolic and skin-health relevance, yet conventional botanical and animal sources provide limited and variable levels. Here we report on the development of a high-yield POA product platform in the heterotrophic microalga Prototheca moriformis through targeted genetic engineering. A Δ9-fatty acid desaturase from Macadamia integrifolia (MiSAD1618) was integrated using a phosphite-based selection system. Primary screening identified stable transformants producing up to 54% POA of total fatty acids, compared to 0.8% in the parental strain. In 1 L shake-flask cultivation, POA reached up to 58.2% of total fatty acids. In a 1 L fed-batch fermentation, the engineered strain accumulated 47.8 g/L of lipids with 43.5% POA after 96 h of fermentation, corresponding to 20.8 g/L of POA. GC–MS analysis of 4,4-dimethyloxazoline (DMOX) derivatives confirmed that the major 16:1 isomer was 16:1 n-7 (Δ9). Together, these results establish P. moriformis as a scalable fermentation platform for producing POA-rich oil and highlight its potential as an efficient alternative source of POA, providing a foundation for further strain and process optimization toward commercial production.